ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

FHS
July 21, 2023
11:04 am

Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

Trump’s FDA commissioner nominee takes the hot seat

Will Marty Makary be confirmed as the next commissioner of the Food and Drug Administration? Will he bring back employees laid off by DOGE? And

March 6, 2025

Why long Covid might predate the pandemic

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for

October 18, 2023

Advocacy leaders condemn reported hate speech directed at LGBTQ+ float at Montrose Fourth of July parade – The Cannabist

Related Articles Colorado LGBTQ+ advocacy leaders on Wednesday condemned reports of hate speech directed toward a Pride float in the Montrose Fourth of July parade.

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.